This inventor holds 1 USPTO granted patent. Top assignee: Noxxon Pharma Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Elisabeth Moyroud: Innovator in Nucleic Acid Technology
Introduction
Elisabeth Moyroud is a prominent inventor based in Graz, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid-based therapeutics. Her innovative work has the potential to impact various medical applications.
Latest Patents
Elisabeth holds a patent for "CGRP binding nucleic acids." This invention relates to an antagonist for CGRP and amylin, where the antagonist is a nucleic acid that binds to CGRP or amylin. The nucleic acid preferably comprises an L-nucleotide, showcasing her expertise in molecular biology and therapeutic development.
Career Highlights
Elisabeth is currently associated with Noxxon Pharma AG, a company focused on developing innovative therapies. Her role at Noxxon Pharma AG allows her to leverage her knowledge and skills in advancing nucleic acid technologies.
Collaborations
Elisabeth has collaborated with notable colleagues, including Sven Klussmann and Thorsten Ruppert. These partnerships have contributed to her research and development efforts in the biotechnology sector.
Conclusion
Elisabeth Moyroud is a trailblazer in the field of nucleic acid technology, with a patent that highlights her innovative approach to medical therapeutics. Her work continues to pave the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile